NCT04857190

Brief Summary

Objectives: To compare the safety and efficacy of Parker flex-it directional stylet (PFDS) versus conventional malleable stylet (CMS) in orotracheal intubation (OTI) using fiber-optic Macintosh laryngoscope. Background: OTI is used in general anesthesia for anesthetic delivery and ventilation of patients. OTI delay or failure may adversely affect patient outcomes, therefore, anesthetists with sufficient clinical experience and skill should perform OTI. However, in emergency situations, experienced anesthetists may not be available, and the patient may have a high Cormack-Lehane grade. A stylet is commonly used in the emergency department to aid insertion of the endotracheal tube during direct laryngoscopy. Patients and Methods: This was a prospective, randomized, double-blind clinical trial; carried out on 80 patients requiring OTI under general anesthesia at our hospital. Patients were randomly allocated into two equal groups; group DS, intubated using PFDS, and group MS, intubated using CMS.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started May 2021

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 21, 2021

Completed
2 days until next milestone

First Posted

Study publicly available on registry

April 23, 2021

Completed
8 days until next milestone

Study Start

First participant enrolled

May 1, 2021

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 15, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 15, 2022

Completed
Last Updated

April 22, 2022

Status Verified

April 1, 2021

Enrollment Period

11 months

First QC Date

April 21, 2021

Last Update Submit

April 15, 2022

Conditions

Keywords

Conventional Malleable StyletOrotracheal IntubationParker Flex-it Directional Stylet

Outcome Measures

Primary Outcomes (1)

  • Mean and Standard deviation of Time required for orotracheal intubation (seconds) (mean±SD)

    Time interval from holding the endotracheal tube by the anesthetist till removal of the stylet from the endotracheal tube by the anesthetist

    2 minutes after inserting the blade of the laryngoscope in the mouth

Secondary Outcomes (8)

  • Mean and Standard deviation of Total time required for orotracheal intubation (seconds) (mean±SD)

    2 minutes after inserting the blade of the laryngoscope in the mouth

  • Mean and Standard deviation of Number of intubation attempts (mean±SD)

    2 minutes after inserting the blade of the laryngoscope in the mouth

  • Number of participants and Rate of Successful intubation from the first-attempt

    2 minutes after inserting the blade of the laryngoscope in the mouth

  • Number of participants and Rate of Use of external laryngeal manipulation

    2 minutes after inserting the blade of the laryngoscope in the mouth

  • Mean and Standard deviation of Heart rate (beat/min.)(mean±SD)

    2 minutes after inserting the blade of the laryngoscope in the mouth

  • +3 more secondary outcomes

Study Arms (2)

Group DS (n=40)

ACTIVE COMPARATOR

Parker Flex-it Directional Stylet group

Device: Parker Flex-it Directional Stylet

Group MS (n=40)

ACTIVE COMPARATOR

Conventional Malleable Stylet group

Device: Conventional Malleable Stylet

Interventions

Parker Flex-it Directional Stylet

Group DS (n=40)

Conventional Malleable Stylet

Group MS (n=40)

Eligibility Criteria

Age21 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • American Society of Anesthesiologists (ASA) physical status ≤ II
  • Age from 21 to 60 years
  • Body Mass Index (BMI) \< 35
  • Mallampati classification ≤ II

You may not qualify if:

  • American Society of Anesthesiologists (ASA) physical status \> II
  • Age \< 21 years or \> 60 years
  • Body Mass Index (BMI) ≥ 35
  • Mallampati classification \> II
  • Pregnant women
  • Anticipated difficult airway
  • Need for rapid sequence induction
  • Increased risk of gastric aspiration such as gastroesophageal reflux
  • Edentulous patients, Loose teeth
  • Known pathology, trauma, or previous surgery to the mouth, pharynx, larynx, or cervical spine
  • History of; Dysrhythmia, Hypertension, Ischemic heart disease, Hyperthyroidism, DM

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Damanhour Teaching Hospital

Damanhūr, El-Beheira, Egypt

Location

Study Officials

  • Ahmed M Shaat, MD

    Damanhour Teaching Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER GOV
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 21, 2021

First Posted

April 23, 2021

Study Start

May 1, 2021

Primary Completion

March 15, 2022

Study Completion

March 15, 2022

Last Updated

April 22, 2022

Record last verified: 2021-04

Locations